Author: GlobeNewswire

PORTLAND, Ore., April 15, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the…

NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…

Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the…

CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic…

TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with urgent clinical needsMore than 500,000…

MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly…

TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”), a dedicated biologics contract development…

Webcast to be held tomorrow, April 16, 2021 at 8:30 AM ETNEW YORK, April 15, 2021 (GLOBE NEWSWIRE) — TG…

STOUGHTON, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host…

Infant Bacterial Therapeutics AB (IBT) today announces that the Chinese patent office has issued a decision to grant approval of…